Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVVD Invivyd, Inc.

休市中 11-22 16:00:00 EST

0.7014

+0.0016

+0.23%

盘后0.6931

-0.0083-1.18%

19:50 EST

最高0.7277	最低0.6872	成交量49.57万
今开0.7159	昨收0.6998	日振幅5.79%
总市值8,390万	流通市值3,210万	总股本1.20亿
成交额35.09万	换手率1.08%	流通股本4,577万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":0.7014,"timestamp":1732309200000,"preClose":0.6998,"halted":0,"volume":495701,"hourTrading":{"tag":"盘后","latestPrice":0.6931,"preClose":0.7014,"latestTime":"19:50 EST","volume":4762,"amount":3367.4974,"timestamp":1732323057291},"delay":0,"floatShares":45765693,"shares":119616035,"eps":-1.938346,"marketStatus":"休市中","marketStatusCode":7,"change":0.0016,"latestTime":"11-22 16:00:00 EST","open":0.7159,"high":0.7277,"low":0.68715,"amount":350902.30137605,"amplitude":0.057945,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.938346,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1628222400000,"adjPreClose":0.6998,"preHourTrading":{"tag":"盘前","latestPrice":0.7197,"preClose":0.6998,"latestTime":"09:04 EST","volume":42,"amount":29.9909988,"timestamp":1732284262058},"postHourTrading":{"tag":"盘后","latestPrice":0.6931,"preClose":0.7014,"latestTime":"19:50 EST","volume":4762,"amount":3367.4974,"timestamp":1732323057291},"volumeRatio":0.63458795034043,"impliedVol":1.1266,"impliedVolPercentile":0.5516},"requestUrl":"/m/hq/s/IVVD/tweets","defaultTab":"tweets","newsList":[{"id":"2485298733","title":"Invivyd, Inc.2024财年第三财季实现净利润-60.74百万美元，同比减少54.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298733?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:02","pubTimestamp":1732291352,"startTime":"0","endTime":"0","summary":"11月23日，Invivyd, Inc.公布财报，公告显示公司2024财年第三财季净利润为-60.74百万美元，同比减少54.01%；其中营业收入为9.30百万美元，每股基本收益为-0.51美元。从资产负债表来看，Invivyd, Inc.总负债78.76百万美元，其中短期债务1.41百万美元，资产负债比为0.03，流动比率为0.02。机构评级：截至2024年11月23日，当前有5家机构对Invivyd, Inc.目标价做出预测，其中目标均价为6.51美元，其中最低目标价为1.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000259a24e496d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000259a24e496d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD"],"gpt_icon":0},{"id":"2484927951","title":"Invivyd, Inc.盘中异动 临近午盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484927951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484927951?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:42","pubTimestamp":1732034529,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时42分，Invivyd, Inc.股票出现异动，股价急速拉升5.20%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Tff Pharmaceuticals, Inc.、Syros Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为813.25%、334.51%、123.17%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为91.10%、81.67%、62.18%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120004210971a77c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120004210971a77c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2483332130","title":"Invivyd 公司报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332130","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332130?lang=zh_cn&edition=full","pubTime":"2024-11-15 05:00","pubTimestamp":1731618000,"startTime":"0","endTime":"0","summary":"Invivyd 公司报告本季度业绩 - 收益摘要Invivyd Inc IVVD.OQ报告本季度调整后每股亏损51美分，低于去年同期的每股收益-36美分。四位分析师对该季度的平均预期是每股亏损 34 美分。Invivyd Inc公布的本季度每股收益为亏损51美分。该公司当季亏损 6,074 万美元。Invivyd Inc本季度股价下跌了12.7%，今年迄今为止亏损了77.4%。华尔街对 Invivyd 公司 12 个月目标价的中位数为 9.00 本摘要由 LSEG 11 月 14 日 08:59 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML1WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2483882445","title":"Invivyd, Inc.盘中异动 大幅跳水5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882445?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:48","pubTimestamp":1731509306,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时48分，Invivyd, Inc.股票出现异动，股价急速跳水5.00%。截至发稿，该股报0.950美元/股，成交量4.308万股，换手率0.04%，振幅3.46%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224826abbde5d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224826abbde5d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2482707100","title":"Invivyd Inc    预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482707100","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482707100?lang=zh_cn&edition=full","pubTime":"2024-11-12 21:54","pubTimestamp":1731419683,"startTime":"0","endTime":"0","summary":"   * Invivyd Inc    将于11月14日公布截至2024年9月30日的财报，预计季度收入将有所增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于马萨诸塞州沃尔瑟姆的公司预计将实现2725万美元的营收。* LSEG 分析师对 Invivyd 公司的平均预期是每股亏损 34 美分。* 华尔街对 Invivyd Inc 的 12 个月目标价中位数为 9.00 美元，高于其最新收盘价 0.98 美元。11月12日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Invivyd Inc    预计每股亏损 34 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD"],"gpt_icon":0},{"id":"2481309100","title":"Invivyd, Inc.盘中异动 早盘急速跳水7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481309100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481309100?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:09","pubTimestamp":1731078553,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时09分，Invivyd, Inc.股票出现波动，股价急速下挫7.00%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823091398e4181a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823091398e4181a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2481985329","title":"Invivyd, Inc.盘中异动 早盘股价大涨7.58%报0.994美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985329?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:34","pubTimestamp":1730903679,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时34分，Invivyd, Inc.股票出现波动，股价急速上涨7.58%。截至发稿，该股报0.994美元/股，成交量2.9576万股，换手率0.02%，振幅2.74%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622343995bddc0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622343995bddc0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2481602121","title":"Invivyd Inc    预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481602121","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481602121?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:00","pubTimestamp":1730901629,"startTime":"0","endTime":"0","summary":"   * Invivyd Inc    预计将在11月11日公布截至2024年9月30日的业绩报告(估计)，季度收入将有所增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于马萨诸塞州沃尔瑟姆的公司预计将实现2725万美元的营收。* LSEG 分析师对 Invivyd 公司的平均预期是每股亏损 34 美分。* 华尔街对 Invivyd Inc 的 12 个月目标价中值为 9.00 美元，高于其 0.92 美元的最新收盘价。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Invivyd Inc    预计每股亏损 34 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD"],"gpt_icon":0},{"id":"2479891286","title":"Invivyd, Inc.盘中异动 早盘大幅下跌5.59%报0.982美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479891286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479891286?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:52","pubTimestamp":1730209933,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时52分，Invivyd, Inc.股票出现波动，股价急速跳水5.59%。截至发稿，该股报0.982美元/股，成交量9.5373万股，换手率0.08%，振幅2.46%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029215213971a2f10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029215213971a2f10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2477535559","title":"Invivyd, Inc.盘中异动 下午盘快速下挫5.34%报0.994美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477535559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477535559?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:02","pubTimestamp":1729702945,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时02分，Invivyd, Inc.股票出现波动，股价急速跳水5.34%。截至发稿，该股报0.994美元/股，成交量7.1089万股，换手率0.06%，振幅5.34%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024010225ab6de67a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024010225ab6de67a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2477086588","title":"Invivyd, Inc.盘中异动 股价大涨5.93%报1.024美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477086588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477086588?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:33","pubTimestamp":1729517583,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时33分，Invivyd, Inc.股票出现波动，股价快速拉升5.93%。截至发稿，该股报1.024美元/股，成交量6640股，换手率0.01%，振幅0.00%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121330398e3d837&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121330398e3d837&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2476438226","title":"Invivyd, Inc.盘中异动 快速上涨5.43%报1.039美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476438226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476438226?lang=zh_cn&edition=full","pubTime":"2024-10-18 03:19","pubTimestamp":1729192757,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日03时19分，Invivyd, Inc.股票出现异动，股价急速上涨5.43%。截至发稿，该股报1.039美元/股，成交量17.855万股，换手率0.15%，振幅6.93%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018031917971a0e71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018031917971a0e71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2475997159","title":"Invivyd, Inc.盘中异动 股价大涨7.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475997159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475997159?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:31","pubTimestamp":1729085465,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时31分，Invivyd, Inc.股票出现异动，股价快速上涨7.22%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621310598e3cc22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621310598e3cc22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2474225788","title":"Invivyd, Inc.盘中异动 股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474225788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474225788?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:37","pubTimestamp":1728481035,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时37分，Invivyd, Inc.股票出现异动，股价快速拉升5.88%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Gri Bio, Inc.较为活跃，换手率分别为628.09%、93.45%、40.03%，振幅较大的相关个股有Cue Biopharma, Inc.、Inhibikase Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为39.02%、22.69%、12.50%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100921371598e3b764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100921371598e3b764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2472574367","title":"Invivyd, Inc.盘中异动 下午盘大幅拉升5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472574367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472574367?lang=zh_cn&edition=full","pubTime":"2024-10-03 01:20","pubTimestamp":1727889623,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日01时20分，Invivyd, Inc.股票出现波动，股价快速上涨5.54%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100301202398e3a3f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100301202398e3a3f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2470089805","title":"Invivyd, Inc.盘中异动 早盘股价大涨5.29%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470089805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470089805?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:38","pubTimestamp":1727444312,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时38分，Invivyd, Inc.股票出现波动，股价大幅上涨5.29%。截至发稿，该股报1.10美元/股，成交量1.6988万股，换手率0.01%，振幅4.81%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213832a1dd10fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213832a1dd10fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2470734109","title":"Invivyd, Inc.盘中异动 早盘大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470734109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470734109?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:37","pubTimestamp":1727357845,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时37分，Invivyd, Inc.股票出现波动，股价大幅上涨5.10%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Eterna Therapeutics Inc.涨幅较大，Pasithea Therapeutics Corp.、Nucana Plc、Theriva Biologics, Inc.较为活跃，换手率分别为2052.05%、103.46%、74.40%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.，振幅分别为32.59%、32.26%、22.37%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262137259719cd4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262137259719cd4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"gpt_icon":0},{"id":"2469311103","title":"Invivyd, Inc.盘中异动 急速拉升5.00%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469311103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469311103?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:32","pubTimestamp":1727098343,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时32分，Invivyd, Inc.股票出现波动，股价急速拉升5.00%。截至发稿，该股报1.26美元/股，成交量5.9928万股，换手率0.05%，振幅1.67%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232132239577c68f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232132239577c68f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2468304055","title":"Invivyd, Inc.盘中异动 下午盘快速上涨8.11%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468304055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468304055?lang=zh_cn&edition=full","pubTime":"2024-09-19 02:00","pubTimestamp":1726682447,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日02时00分，Invivyd, Inc.股票出现异动，股价快速拉升8.11%。截至发稿，该股报1.20美元/股，成交量10.4769万股，换手率0.09%，振幅5.86%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409190200479719bb18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409190200479719bb18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0},{"id":"2468350322","title":"Invivyd, Inc.盘中异动 早盘股价大跌5.01%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468350322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468350322?lang=zh_cn&edition=full","pubTime":"2024-09-17 21:38","pubTimestamp":1726580332,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日21时38分，Invivyd, Inc.股票出现异动，股价大幅下挫5.01%。截至发稿，该股报1.08美元/股，成交量7779股，换手率0.01%，振幅4.11%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409172138529719b885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409172138529719b885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.invivyd.com","stockEarnings":[{"period":"1week","weight":-0.0711},{"period":"1month","weight":-0.2902},{"period":"3month","weight":-0.3055},{"period":"6month","weight":-0.6366},{"period":"1year","weight":-0.5324},{"period":"ytd","weight":-0.822}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Invivyd, Inc.于2020年6月3日在特拉华州成立。该公司是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。他们正在开发他们的主要候选产品ADG20，用于治疗和预防冠状病毒病，即由病毒SARS-CoV-2及其变体引起的疾病。他们旨在通过构建具有广泛中和活性的抗体组合来应对COVID-19和未来潜在的病毒爆发，这些抗体对冠状病毒家族的多个成员或具有大流行潜力的其他病毒具有广泛的中和活性。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.23988},{"month":2,"riseRate":0,"avgChangeRate":-0.160396},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.16632},{"month":4,"riseRate":0,"avgChangeRate":-0.318713},{"month":5,"riseRate":0.666667,"avgChangeRate":0.166719},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.236911},{"month":7,"riseRate":1,"avgChangeRate":0.206353},{"month":8,"riseRate":0.666667,"avgChangeRate":0.077457},{"month":9,"riseRate":0.5,"avgChangeRate":0.012082},{"month":10,"riseRate":0.25,"avgChangeRate":-0.060343},{"month":11,"riseRate":0.25,"avgChangeRate":-0.016214},{"month":12,"riseRate":0.333333,"avgChangeRate":0.131072}],"exchange":"NASDAQ","name":"Invivyd, Inc.","nameEN":"Invivyd, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Invivyd, Inc.,IVVD,Invivyd, Inc.股票,Invivyd, Inc.股票老虎,Invivyd, Inc.股票老虎国际,Invivyd, Inc.行情,Invivyd, Inc.股票行情,Invivyd, Inc.股价,Invivyd, Inc.股市,Invivyd, Inc.股票价格,Invivyd, Inc.股票交易,Invivyd, Inc.股票购买,Invivyd, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}